Davis Kimberly, Bellini Paula, Hagerman Charlotte, Zinar Riley, Leigh Daniel, Hoffman Richard, Aaronson David, Van Den Eeden Stephen, Philips George, Taylor Kathryn
Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.
Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.
Urology. 2017 Sep;107:86-95. doi: 10.1016/j.urology.2017.02.056. Epub 2017 Apr 25.
To assess physicians' attitudes regarding multiple factors that may influence recommendations for active surveillance (AS) vs active treatment (AT) given the central role physicians play in the treatment decision-making process.
We conducted semistructured interviews to assess factors that physicians consider important when recommending AS vs AT, as well as physicians' perceptions of what their patients consider important in the decision. Participants included urologists (N = 11), radiation oncologists (N = 12), and primary care physicians (N = 10) from both integrated and fee-for-service healthcare settings.
Across the specialties, quantitative data indicated that most physicians reported that their recommendations for AS were influenced by patients' older age, willingness and ability to follow a surveillance protocol, anxiety, comorbidities, life expectancy, and treatment preferences. Qualitative findings highlighted physicians' concerns about malpractice lawsuits, given the possibility of disease progression. Additionally, most physicians noted the role of the healthcare setting, suggesting that financial incentives may be associated with AT recommendations in fee-for-service settings. Finally, most physicians reported spouse or family opposition to AS due to their own anxiety or lack of understanding of AS.
We found that patient and physician preferences, healthcare setting, and family or spouse factors influence physicians' treatment recommendations for men with low-risk PCa. These were consistent themes across physician subspecialties in both an Health Maintenance Organization and in fee-for-service settings.
鉴于医生在治疗决策过程中发挥的核心作用,评估医生对可能影响主动监测(AS)与主动治疗(AT)建议的多种因素的态度。
我们进行了半结构化访谈,以评估医生在推荐AS与AT时认为重要的因素,以及医生对患者在决策中认为重要因素的看法。参与者包括来自综合医疗和按服务收费医疗环境的泌尿科医生(N = 11)、放射肿瘤学家(N = 12)和初级保健医生(N = 10)。
在各个专业中,定量数据表明,大多数医生报告称,他们对AS的建议受到患者年龄较大、遵循监测方案的意愿和能力、焦虑、合并症、预期寿命以及治疗偏好的影响。定性研究结果突出了医生对医疗事故诉讼的担忧,因为存在疾病进展的可能性。此外,大多数医生指出了医疗环境的作用,表明在按服务收费的环境中,经济激励可能与AT建议有关。最后,大多数医生报告称,配偶或家人因自身焦虑或对AS缺乏了解而反对AS。
我们发现,患者和医生的偏好、医疗环境以及家庭或配偶因素会影响医生对低风险前列腺癌男性患者的治疗建议。在健康维护组织和按服务收费的环境中,这些是各医生亚专业中一致的主题。